Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Fusen Pharmaceutical Company Limited |
| Zhejiang Hisun Pharmaceutical Co., Ltd. |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. |
| Jiangsu Yahong Meditech Co., Ltd. |
| Shouyao Holdings (Beijing) Co., LTD. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 1,652 | 600,267 | 688,505 | 688,176 | 688,197 | 2,750 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -16% | 0% | 2% | -17% | -21% | -10% | ||
| Fiscal Year - 1 | -5% | 6% | 5% | -16% | -17% | -9% | ||
| Fiscal Year - 2 | 3% | 7% | 6% | -9% | -29% | 0% | ||
| Fiscal Year - 3 | 11% | 6% | 10% | -12% | -196% | 2% | ||
| Fiscal Year - 4 | 8% | 1% | 11% | NA | -206% | -4% | ||
| Fiscal Year - 5 | 26% | -8% | 24% | NA | -57% | 2% | ||
| Average | 4% | 2% | 10% | -13% | -88% | -3% | ||
| Median | 5% | 4% | 8% | -14% | -43% | -2% | ||
| Benchmarks | Ticker | |||||||
| Fusen Pharmaceutical Company Limited | SEHK:1652 | |||||||
| Zhejiang Hisun Pharmaceutical Co., Ltd. | SHSE:600267 | |||||||
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. | SHSE:688505 | |||||||
| Jiangsu Yahong Meditech Co., Ltd. | SHSE:688176 | |||||||
| Shouyao Holdings (Beijing) Co., LTD. | SHSE:688197 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | Jul-04 | Jun-43 | Jan-85 | Feb-84 | Mar-84 | Jul-07 | ||
| Latest Fiscal Year | Dec-23 | Dec-23 | Dec-24 | Dec-24 | Dec-24 | Dec-23 | ||
| LTM Period | Jun-24 | Sep-24 | Dec-24 | Dec-24 | Dec-24 | Sep-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 425 | 9,547 | 709 | 202 | 4 | 62 | ||
| Fiscal Year | 566 | 10,373 | 709 | 202 | 4 | 87 | ||
| Fiscal Year - 1 | 492 | 12,037 | 851 | 14 | 5 | 123 | ||
| Fiscal Year - 2 | 386 | 12,136 | 1,031 | 0 | 2 | 703 | ||
| Fiscal Year - 3 | 487 | 11,354 | 1,140 | 0 | 13 | 254 | ||
| Fiscal Year - 4 | 407 | 11,072 | 834 | NA | 7 | 275 | ||
| Fiscal Year - 5 | 462 | 10,187 | 1,029 | NA | 12 | 336 | ||
| Net Income | ||||||||
| Latest Twelve Months | (90) | (20) | 40 | (388) | (201) | (54) | ||
| Fiscal Year | (36) | (93) | 40 | (388) | (201) | (71) | ||
| Fiscal Year - 1 | (35) | 489 | 109 | (400) | (186) | (56) | ||
| Fiscal Year - 2 | 17 | 487 | 138 | (247) | (174) | 3 | ||
| Fiscal Year - 3 | 70 | 417 | 213 | (235) | (145) | 12 | ||
| Fiscal Year - 4 | 53 | 93 | 165 | (247) | (330) | (23) | ||
| Fiscal Year - 5 | 102 | (492) | 227 | (172) | (40) | 14 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 1,312 | 18,147 | 2,877 | 2,632 | 1,112 | 683 | ||
| Latest Fiscal Quarter | 1,337 | 16,257 | NA | NA | NA | 597 | ||
| Fiscal Year | 1,344 | 17,613 | NA | NA | NA | 632 | ||
| Fiscal Year - 1 | 1,350 | 18,778 | 2,877 | 2,632 | 1,112 | 747 | ||
| Fiscal Year - 2 | 1,239 | 19,374 | 2,976 | 2,874 | 1,299 | 827 | ||
| Fiscal Year - 3 | 1,241 | 20,860 | 2,781 | 3,099 | 58 | 842 | ||
| Fiscal Year - 4 | 1,176 | 21,466 | 2,501 | 844 | 177 | 807 | ||
| Fiscal Year - 5 | 1,163 | 21,854 | 1,565 | 73 | 219 | 788 | ||
| Fiscal Year - 6 | 951 | 21,636 | 1,470 | 66 | 57 | 785 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 622 | 8,586 | 2,358 | 2,388 | 1,021 | 556 | ||
| Latest Fiscal Quarter | 520 | 8,253 | 2,352 | 2,078 | 861 | 503 | ||
| Fiscal Year | 564 | 8,102 | 2,352 | 2,078 | 861 | 512 | ||
| Fiscal Year - 1 | 614 | 8,079 | 2,358 | 2,388 | 1,021 | 583 | ||
| Fiscal Year - 2 | 658 | 7,303 | 2,257 | 2,771 | 1,207 | 639 | ||
| Fiscal Year - 3 | 659 | 6,679 | 2,193 | 3,013 | 2 | 636 | ||
| Fiscal Year - 4 | 673 | 6,274 | 2,011 | 806 | 146 | 624 | ||
| Fiscal Year - 5 | 614 | 6,183 | 932 | 29 | 174 | 647 | ||
| Fiscal Year - 6 | 181 | 6,723 | 943 | 47 | (36) | 646 | ||